首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1392066

救援吸入器市場：按產品類型、按適應症、按患者類型、按劑型、按最終用戶、按地區

Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography

出版日期: 2023年11月06日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

救援吸入器市場規模預計將從 2023 年的 155 億美元增加到 2030 年的 279 億美元，預測期內年複合成長率為 8.8%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	155億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	8.80%	2030年市場規模預測	279億美元

圖 1. 2023 年按地區分類的救援吸入器市場佔有率(%)

救援吸入器，也稱為緩解吸入器，是患有氣喘或慢性阻塞性肺病(COPD) 等呼吸系統疾病的人常用的藥物裝置。它含有速效支氣管擴張劑，可在氣喘發作或呼吸困難時打開氣道。這種藥物可以快速緩解喘息、氣短和胸悶等症狀。救援吸入器可以快速緩解症狀，但不能治療症狀的根本原因。它是管理急性呼吸道症狀和改善患者生活品質的重要工具。

市場動態：

呼吸系統疾病盛行率的上升、老年人口的增加以及醫療保健支出的增加預計將在預測期內推動全球救援吸入器市場的成長。此外，技術進步預計也將在預測期內推動全球救援吸入器市場的成長。新興市場的高成長潛力、居家照護需求的成長、氣喘生技藥品的市場開拓以及對呼吸照護遠端醫療醫療的日益關注將推動全球救援吸入器市場在預測期內帶來機會。

然而，嚴格的監管要求、吸入器的副作用以及吸入器的高成本預計將阻礙預測期內救援吸入器市場的成長。

本研究的主要特點

該報告詳細分析了救援吸入器市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還闡明了不同細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了救援吸入器市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
救援吸入器市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析救援吸入器市場的各種策略矩陣，將有助於相關人員做出決策。

市場動態
- 促進因素
呼吸道疾病盛行率上升
老年人口增加
增加產品核准
- 抑制因素
嚴格的監管要求
產品召回
吸入器很貴
- 機會
呼吸照護遠端醫療醫療日益受到關注
氣喘生物製藥的開發
新興市場的高成長潛力
影響分析
主要亮點
監管場景
產品發布/核准
PEST分析
波特的分析
併購場景

第4章救援吸入器市場－冠狀病毒（COVID-19）大流行的影響

新型冠狀病毒感染疾病（COVID-19）的流行病學
供需面分析
經濟影響

第5章救援吸入器市場，依產品類型，2018-2030

定量吸入器
乾粉吸入器
噴霧器
軟霧吸入器
其他

第6章救援吸入器市場，依適應症分類，2018-2030 年

氣喘
COPD
過敏性鼻炎
肺動脈高血壓
其他

第 7 章救援吸入器市場，依病患類型，2018-2030 年

成人
兒童

第 8 章救援吸入器市場，按劑型，2023-2030 年

膠囊
解決方案
暫停
其他

第 9 章救援吸入器市場，依最終使用者分類，2018-2030 年

居家照護環境
醫院和診所

第10章救援吸入器市場，按地區，2018-2030

北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
南非
中部非洲

第11章競爭形勢

GSK plc.
Teva Pharmaceutical Industries Ltd.
Cipla Inc.
PARI Pharma GmbH
Lupin
AstraZeneca
Boehringer Ingelheim International GmbH.
Novartis
Pfizer
Sunovion Pharmaceuticals
3M
OMRON Healthcare Co., Ltd.
Koninklijke Philips NV
Invacare
Schiller
Teleflex Incorporated

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6208

The Rescue Inhaler Market size is expected to reach US$ 27.9 billion by 2030, from US$ 15.5 billion in 2023, at a CAGR of 8.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 15.5 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.80%	2030 Value Projection:	US$ 27.9 Bn

Figure 1. Rescue Inhaler Market Share (%), By Region, 2023

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market

Detailed Segmentation:

By Product Type:
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Soft Mist Inhalers
- Others
By Indication:
- Asthma
- COPD
- Allergic Rhinitis
- Pulmonary Arterial Hypertension
- Others
By Patient Type:
- Adult
- Pediatric
By Dosage Form:
- Capsules
- Solution
- Suspension
- Others
By End User:
- Home Care Settings
- Hospitals & Clinics
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- Omron Healthcare
- Koninklijke Philips N.V.
- Invacare
- Schiller
- Teleflex Incorporated

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By Patient Type
- Market Snippet, By Dosage Form
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of respiratory diseases
Increasing geriatric population
Increasing Product Approval
- Restraints
Stringent regulatory requirements
Product Recall
High cost of inhalers
- Opportunities
Rising focus on telehealth for respiratory care
Development of biologics for asthma
High growth potential in emerging markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Rescue Inhaler Market, By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Metered Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Dry Powder Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Rescue Inhalers Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Rescue Inhalers Market, By Patient Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Rescue Inhalers Market, By Dosage Form, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Rescue Inhalers Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Rescue Inhalers Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
North Africa
South Africa
Central Africa

11. Competitive Landscape

GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
Cipla Inc.
PARI Pharma GmbH
Lupin
AstraZeneca
Boehringer Ingelheim International GmbH.
Novartis
Pfizer
Sunovion Pharmaceuticals
3M
OMRON Healthcare Co., Ltd.
Koninklijke Philips N.V.
Invacare
Schiller
Teleflex Incorporated
Analyst Views